AHR and urinary bladder cancer: In addition, it was found that the recurrent in-frame deletions of exons 8 and 9 in the AhR gene displayed a high prevalence in bladder cancer comprising ~ 10 % of patients, which is highly specific to urinary tract cancer and mutually exclusive with other bladder cancer drivers [13].